ImmunoPrecise Antibodies Ltd.

DB:TQB Stock Report

Market Cap: €11.3m

ImmunoPrecise Antibodies Future Growth

Future criteria checks 4/6

ImmunoPrecise Antibodies is forecast to grow earnings and revenue by 72.8% and 19.7% per annum respectively while EPS is expected to grow by 73.5% per annum.

Key information

72.8%

Earnings growth rate

73.5%

EPS growth rate

Life Sciences earnings growth26.4%
Revenue growth rate19.7%
Future return on equityn/a
Analyst coverage

Low

Last updated18 Sep 2024

Recent future growth updates

No updates

Recent updates

Earnings and Revenue Growth Forecasts

DB:TQB - Analysts future estimates and past financials data (CAD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
4/30/202742-1N/AN/A1
4/30/202634-6N/AN/A1
4/30/202525-13N/AN/A2
7/31/202424-28-7-6N/A
4/30/202425-27-6-4N/A
1/31/202424-14-5-4N/A
10/31/202323-16-8-7N/A
7/31/202322-21-12-10N/A
4/30/202321-27-21-20N/A
1/31/202320-26-21-19N/A
10/31/202220-25-23-21N/A
7/31/202219-23-20-19N/A
4/30/202219-17-11-10N/A
1/31/202219-17-10-9N/A
10/31/202119-15-6-4N/A
7/31/202119-10-4-2N/A
4/30/202118-7-2-1N/A
1/31/202117-3-11N/A
10/31/202017-301N/A
7/31/202015-3-1-1N/A
4/30/202014-5-2-1N/A
1/31/202013-8-3-3N/A
10/31/201911-8-4-3N/A
7/31/201911-9-4-3N/A
4/30/201911-8-4-3N/A
1/31/201910-6-4-3N/A
10/31/20189-6-4-3N/A
7/31/20188-5-3-2N/A
4/30/20185-5N/A-3N/A
1/31/20184-4N/A-3N/A
10/31/20173-7N/A-3N/A
7/31/20172-6N/A-2N/A
4/30/20173-5N/A-1N/A
1/31/20173-4N/A0N/A
10/31/201631N/A1N/A
7/31/201620N/A0N/A
4/30/201620N/A0N/A
4/30/201520N/A0N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: TQB is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (1%).

Earnings vs Market: TQB is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: TQB is expected to become profitable in the next 3 years.

Revenue vs Market: TQB's revenue (19.7% per year) is forecast to grow faster than the German market (5.4% per year).

High Growth Revenue: TQB's revenue (19.7% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if TQB's Return on Equity is forecast to be high in 3 years time


Discover growth companies